HOME >> BIOLOGY >> NEWS
Malaria parasite impairs key immune system cells

Plasmodium, the parasite responsible for malaria, impairs the ability of key cells of the immune system to trigger an efficient immune response. This might explain why patients with malaria are susceptible to a wide range of other infections and fail to respond to several vaccines. In a study published today in the open access journal Journal of Biology (http://jbiol.com/), researchers show that if dendritic cells, the key cells involved in initiating immunity, are exposed to red blood cells infected with Plasmodium chabaudi, they initiate a sequence of events that result in compromised antibody responses. The researchers show that this is due to the presence of hemozoin, a by-product of the digestion of hemoglobin by Plasmodium, in infected red blood cells. These observations also explain why vaccines for many diseases are so ineffective during malaria infection, and suggest that the use of preventive anti-malarial drugs before vaccination may improve vaccine-induced protection.

In a study funded by the Wellcome Trust, Owain Millington and colleagues from the University of Strathclyde, UK, studied the effects of Plasmodium chabaudi, the mouse Plasmodium, on mice antigen-presenting dendritic cells in culture and confirmed their findings in live mice.

Millington et al.'s results show that dendritic cells exposed to P. chabaudiinfected red blood cells do not activate normally. They express lower levels of membrane molecules that stimulate other cells of the immune system, and their cytokine production is lower than that of normal dendritic cells. Millington et al. demonstrate that this is caused by exposure to hemozoin present in infected red blood cells.

Millington et al. then show that P.chabaudi-infected dendritic cells fail to activate helper T cells properly T cells are activated but show reduced proliferation and cytokine production in culture. Importantly, during malaria infection, T cells fail to migrate to B-cell areas of lymph nodes
'"/>

Contact: Juliette Savin
juliette.savin@biomedcentral.com
44-207-631-9931
BioMed Central
11-Apr-2006


Page: 1 2

Related biology news :

1. Malaria -- Effective insecticide-repellent synergy against mosquito vectors
2. Malaria-resistant mosquitoes battle disease with molecular warhead
3. Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
4. Malaria in pregnancy: What can the social sciences contribute?
5. Malaria: The right vaccine in the right place?
6. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
7. 20 Years of Malaria Research: Outcomes and Perspectives
8. Malaria poses additional risks for first-time mothers
9. Malaria drug may treat metabolic syndromes many symptoms
10. Malaria: Efficacy of monotherapies in Cameroon
11. Malaria, potato famine pathogen share surprising trait

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2019)... ... February 12, 2019 , ... Ava, a 115-pound Newfoundland, ... partially tore one of her cruciate ligaments. Just one year later, she suffered ... was able to recover without surgical intervention and resumed her normal activities without any ...
(Date:2/11/2019)... WASHINGTON (PRWEB) , ... February 11, 2019 , ... ... an Allotrope™ Data Model (ADM), completing the phased release of the Allotrope™ Framework ... new capability combines with the previously released Allotrope™ Data Format (ADF) and application ...
(Date:2/2/2019)... ... January 31, 2019 , ... Pharmica Consulting announced it will ... and focusing on all facets of clinical trial planning and management. Pharmica ... management, patient engagement, and more. , “We have attended the SCOPE Summit ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... ... January 22, 2019 , ... Dr. Douglas Stramel of ... Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly three years. A ... Cell Therapy since 2007 and began using V-PET™ 2016. V-PET™ is a ...
(Date:1/20/2019)... ... January 17, 2019 , ... Consumers are directing healthcare ... of physicians. That's changing as many services now exist for patients to order ... market totaled $208 million in 2018, according to Kalorama Information’s new report, ...
(Date:1/15/2019)... ... January 15, 2019 , ... With the U.S. Congress designating January as Cervical Health ... testing service, today announces tips to help reduce the risk of Cervical Cancer. , ... Genital HPV is the #1 most common STD and an STI that almost ...
(Date:1/10/2019)... ... ... VGI Medical was founded in 2007 based on an invention developed by Tov ... VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are specifically designed to ... to limit motion of the affected spinal segment. Applying the principles of this success, ...
Breaking Biology Technology:
Cached News: